MDM2 Copy Numbers in Well Differentiated and Dedifferentiated Liposarcoma: Where Do We Draw the Line?

被引：0
|
作者：
Ware, P. [1 ]
Snow, A. [1 ]
Pettenati, M. [1 ]
Qasem, S. [1 ]
机构：
[1] Wake Forest Univ, Baptist Med Ctr, Winston Salem, NC 27109 USA
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
82
引用
收藏
页码：22A / 22A
页数：1
相关论文
共 50 条
  • [41] Dedifferentiated Liposarcoma and Pleomorphic Liposarcoma: A Comparative Study on FNA Cytomorphology and MDM2/CDK4 Expression
    Marino-Enriquez, A.
    Hornick, J. L.
    Cibas, E. S.
    Qian, X.
    LABORATORY INVESTIGATION, 2013, 93 : 97A - 97A
  • [42] Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma:: Special emphasis on the distinct immunophenotype of the well-differentiated component
    Adachi, T
    Oda, Y
    Sakamoto, A
    Saito, T
    Tamiya, S
    Masuda, I
    Tsuneyoshi, M
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2001, 9 (02) : 99 - 109
  • [43] Well-Differentiated Laryngeal/Hypopharyngeal Liposarcoma in the MDM2 Era Report of Three Cases and Literature Review
    Zhu H.
    Sun J.
    Wei S.
    Wang D.
    Brandwein M.
    Head and Neck Pathology, 2017, 11 (2) : 146 - 151
  • [44] Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
    Ray-Coquard, Isabelle
    Blay, Jean-Yves
    Italiano, Antoine
    Le Cesne, Axel
    Penel, Nicolas
    Zhi, Jianguo
    Heil, Florian
    Rueger, Ruediger
    Graves, Bradford
    Ding, Meichun
    Geho, David
    Middleton, Steven A.
    Vassilev, Lyubomir T.
    Nichols, Gwen L.
    Binh Nguyen Bui
    LANCET ONCOLOGY, 2012, 13 (11): : 1133 - 1140
  • [45] A case of dedifferentiated liposarcoma with well-differentiated liposarcomatous, inflammatory myofibroblastic tumor-like, and low- and high-grade osteosarcomatous components: common MDM2 amplification supporting divergent morphological change of well-differentiated liposarcoma
    Tajima, Shogo
    Koda, Kenji
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 2382 - 2388
  • [46] Fine needle aspiration biopsy diagnosis of dedifferentiated liposarcoma: Cytomorphology and MDM2 amplification by FISH
    Al-Maghraby, Hatem Q.
    Khalbuss, Walid E.
    Rao, Uma N. M.
    Cieply, Kathleen
    Dacic, Sanja
    Monaco, Sara E.
    CYTOJOURNAL, 2010, 7
  • [47] Modulation of MDM2 alters the metabolomic programming of dedifferentiated liposarcoma and its sensitivity to cholesterol inhibition
    Demoret, Bryce
    Patt, Andrew
    Hays, John
    Mathe, Ewy
    Chen, James L.
    CANCER RESEARCH, 2018, 78 (13)
  • [48] Prognostic significance of the MDM2/HMGA2 ratio and histological tumor grade in dedifferentiated liposarcoma
    Yamashita, Kyoko
    Kohashi, Kenichi
    Yamada, Yuichi
    Akatsuka, Shinya
    Ikuta, Kunihiro
    Nishida, Yoshihiro
    Toyokuni, Shinya
    Oda, Yoshinao
    GENES CHROMOSOMES & CANCER, 2021, 60 (01): : 26 - 37
  • [49] MDM2 antagonists synergize with PI3K/mTOR inhibition in well-differentiated/dedifferentiated liposarcomas
    Laroche, Audrey
    Chaire, Vanessa
    Algeo, Marie-Paule
    Karanian, Marie
    Fourneaux, Benjamin
    Italiano, Antoine
    ONCOTARGET, 2017, 8 (33) : 53968 - 53977
  • [50] The upper temperature for life - where do we draw the line?
    Cowan, DA
    TRENDS IN MICROBIOLOGY, 2004, 12 (02) : 58 - 60
12345